![Dollar edges higher on Trump expectations; euro slips ahead of inflation data](https://i-invdn-com.investing.com/news/LYNXMPEEB40Y1_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.630 | 100.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.599 | 21.824 |
Price to Book | 3.388 | 4.011 |
Price to Sales | 1.925 | 2.265 |
Price to Cash Flow | 16.488 | 16.912 |
Dividend Yield | 0.482 | 1.338 |
5 Years Earnings Growth | 19.264 | 11.420 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.780 | 94.954 |
Consumer Defensive | 2.220 | 3.902 |
Number of long holdings: 35
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum | SE0000872095 | 9.70 | 283.80 | -0.70% | |
Zealand Pharma | DK0060257814 | 8.73 | 919.00 | +0.71% | |
UCB | BE0003739530 | 5.28 | 140.95 | +0.50% | |
Sanofi | FR0000120578 | 4.79 | 91.12 | -0.79% | |
Avadel Pharma | IE00BDGMC594 | 4.42 | 14.120 | +0.43% | |
Intuitive Surgical | US46120E6023 | 3.93 | 436.24 | -1.94% | |
Cytokinetics Inc | US23282W6057 | 3.88 | 54.70 | +0.96% | |
Argen-X | NL0010832176 | 3.68 | 404.00 | +0.12% | |
HCA | US40412C1018 | 3.58 | 315.12 | -1.92% | |
Global Health | INE474Q01031 | 3.27 | 1,284.60 | +1.11% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology FunD E | 7.01B | 15.47 | 4.46 | 16.64 | ||
Global Technology Fund I E | 7.01B | 15.47 | 5.56 | 17.84 | ||
Global Technology Fund RE | 7.01B | 15.23 | 5.03 | 17.32 | ||
IE00BTN23623 | 7.01B | 23.86 | -4.04 | - | ||
IE00BZ4D7648 | 7.01B | 23.96 | -4.03 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review